Molnupiravir Armageddon

Molnupiravir Extends COVID-19 Viral Phase, Evidenced by the High Frequency of Rare and Dangerous Mutations in SARS-COV-2, preprint, 2021-12-20 Unexpected Mildness of Host-Induced Mutations in SARS-COV-2, preprint, 2021-12-08 Treating a Pandemic Respiratory Disease with a Mutagen is a Doomsday Scenario, preprint, 2021-12-02 AMDAC used the decision-making process in authorization of Remdesivir (Remdeathivir) as the precedent … Continue reading Molnupiravir Armageddon